Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases
Bone Marrow Transplant
.
2023 Jan;58(1):109-111.
doi: 10.1038/s41409-022-01844-x.
Epub 2022 Oct 19.
Authors
Maria Gabelli
1
2
,
Polina Stepensky
3
,
Giorgio Ottaviano
4
,
Khushnuma Mullanfiroze
4
,
Arina Lazareva
4
,
Irina Zaidman
3
,
Ehud Even-Or
3
,
Giovanna Lucchini
4
,
Robert Chiesa
4
,
Juliana Silva
4
,
Stuart Adams
5
,
Susanne Kricke
5
,
Maria Finch
4
,
Annette Hill
4
,
Rachel Mead
4
,
Delphine Veys
6
,
Yael Dinur Schejter
3
,
Adeeb Naser Eddin
3
,
Austen Worth
7
,
Persis J Amrolia
4
,
Kanchan Rao
4
Affiliations
1
Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, UK.
[email protected]
.
2
Pediatric Hematology, Oncology and Stem Cell Transplantation, Università degli studi di Padova, Padova, Italy.
[email protected]
.
3
Bone Marrow Transplantation, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
4
Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, UK.
5
Specialist Integrated Hematology and Malignancy Diagnostic Service, Hematology, Great Ormond Street Hospital for Children, London, UK.
6
St John's College, Cambridge, UK.
7
Immunology, Great Ormond Street Hospital for Children, London, UK.
PMID:
36261706
DOI:
10.1038/s41409-022-01844-x
No abstract available
Publication types
Letter
MeSH terms
Child
Chimerism
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Lymphocyte Transfusion
Lymphocytes
Transplantation Chimera